Linkedin Twitter
Book a demo
Book a demo

Where purpose meets passion.

As a team of researchers, doctors and engineers, we are driven by our singular mission: enhance neurologic care

neuroClues' mission

In a world where neurological disorders will affect 1 person in 3 and where the number of Parkinson’s patients will double in the next decade, reaching 13 million patients, our mission is to empower clinicians with biomarkers allowing them to identify neurological disorders (Parkinson’s Disease, Alzheimer’s Disease, and Multiple Sclerosis) years before visible symptoms.

Our goal is to support 10M patients by 2030.

We are…

  • a pragmatic healthcare company empowering people.
  • ambitious. We are coming with an innovation that aims to disrupt the current clinical practice of neurologists
  • trustworthy. We are researchers, doctors & engineers, inspired by science and passionate about the benefits of eye-tracking for the daily use of health practitioners.

neuroClues' mission

In a world where neurological disorders will affect 1 person in 3 and where the number of Parkinson’s patients will double in the next decade, reaching 13 million patients, our mission is to empower clinicians with biomarkers allowing them to identify neurological disorders (Parkinson’s Disease, Alzheimer’s Disease, and Multiple Sclerosis) years before visible symptoms.

Our goal is to support 10M patients by 2030.

We are…

  • a pragmatic healthcare company empowering people.
  • ambitious. We are coming with an innovation that aims to disrupt the current clinical practice of neurologists
  • trustworthy. We are researchers, doctors & engineers, inspired by science and passionate about the benefits of eye-tracking for the daily use of health practioners.

P3Lab was co-founded in 2020 by Pierre Daye, Pierre Pouget and Antoine Pouppez, former ICM and IBA employees. Pierre Daye earned his PhD in the applied mathematics department of UCLouvain in Belgium working on modeling and analysis of eye and head coordination. He did a series of post-docs and met Pierre Pouget, recognized CNRS researcher working with key opinion leaders in neuroscience at the Institute for Brain and Spinal Cord (ICM) in Paris. Together they pursued studies of eye movements through modeling and experimental research projects. During their combined +35 years of research, they faced the pains linked with the use of eye tracking and decided with the help of Antoine Pouppez to tackle these issues and develop a medical device (NeuroClues™) based on eye tracking to support early diagnose of neurological diseases and allows eye tracking to deliver its full potential to the clinical practice.

In November 2021, the team raised a € 4,7 million Seed round to bring this disruptive deep tech innovation to the European and US markets. It was followed in 2022 by the announcement of a € 2.5 million grant and up to € 9 million in upcoming equity from the EIC Accelerator. In 2024, the company announced a € 5 millions pre-Serie A round to achieve regulatory approvals in Europe and US, and start the commercial deployment in the US. 

We are an empowering organisation with a strong culture of Trust, Respect, Quality, and Pragmatism.

iPeps logo

The team consists of about 20 collaborators spread on 2 offices:

  • the headquarter with the manufacturing facility in Louvain-la-Neuve, Belgium and
  • an office located at La Pitié Salpétrière, iPEPS, the first incubator dedicated to brain diseases in France.

Investors material

Meet the neuroClues® team

Executive team

Antoine Pouppez

CEO & co-founder

Linkedin

Pierre Daye

CTO & co-founder

Linkedin
Gaetan-scaled_RET

Gaëtan Vanhoutte

Product manager

Linkedin

Frédérique Boël

Head of QARA

Linkedin

Jean-Baptiste de Harenne

Chief Market Officer

Linkedin

Philippe Domineaux

Head of IT

Linkedin

Bart Stulens

Chief Commercial Officer

Linkedin

Audrey Bonnan

Head of Clinical

Linkedin

Advisors

Pierre Pouget

Scientific Advisor & co-founder

Linkedin

Tymothée Poitou

Clinical Advisor

Linkedin

Bao Nguyen

Marketing Advisor

Linkedin

Board of directors

Marie Vidailhet, MD, PUPH

Director

Olivier Legrain

President

Diane Lejeune

Director

Our scientific board

Bertrand Gaymard

Bertrand Gaymard

Neurologist

Aasef Shaikh

Aaseif G. Shaikh

Neurologist

Marie-Laure Laborie

Orthoptist

Alessandra Rufa

Alessandra Rufa

Neurologist – Ophtamologist

Eve Kannengieser

Orthoptist

Thérèse Collins

Professor of cognitive science

neuroClues is powered by P3Lab SRL
VAT: BE 0750.746.841

Centre Monnet – Av. Jean Monnet, 1 – 1348 Louvain-la-Neuve – Belgium
iPeps Incubator – 187 rue Chevaleret – 75013 Paris – France

Our development is financed with the support of the Walloon Region and the European Innovation Council

neuroClues is powered by P3Lab SRL 
VAT: BE 0750.746.841

Centre Monnet – Av. Jean Monnet, 1 – 
1348 Louvain-la-Neuve – Belgium
iPeps Incubator – 187 rue Chevaleret – 75013 Paris – France

Our development is financed with
the support of the Walloon Region and the European Innovation Council

© Neuroclues 2024 – all rights reserved

Regulatory disclaimer
Privacy policy
Privacy notice (US)
Cookie policy

Change cookie preferences

Made by Axiocom

Antoine Pouppez

CEO & co-founder

Linkedin

Antoine Pouppez is a father of three daughters and bioengineer dedicated to the medical device field with a track record of converting ideas into reality. He is passionate about empowering people and committed to positively impact humankind by giving a small fraction back of what our society has invested in him.

His purpose as CEO and co-founder is to bring pragmatic healthcare innovations to patients that empower practitioners to provide the best care.

Pierre Daye

CTO

Linkedin

Pierre M. Daye earned his PhD in the applied mathematics department of UCLouvain in Belgium working on modeling and analysis of eye and head coordination. 
Then, he did a series of post-docs (NIH, Brain and Spine Institute and Vision Institute) pursuing his studies of eye movements through modeling and experimental research projects. 

Pierre is passionate about eye movements, their link to neuronal mechanisms and how they can be used to help the diagnosis of neuronal diseases.

As a co-founder and CTO of P3Lab, Pierre develops a solution that solves 15+ years of pains linked with the use of eye tracking, transforming it into a robust and ergonomic ally in the daily clinical use.

Gaetan-scaled_RET

Gaëtan Vanhoutte

Product Manager

Linkedin

Driven by his passion for medical devices, Gaëtan holds a biomedical engineering degree from the UCLouvain and cumulates since then several professional experiences in this field. From radiation oncology to diagnostic laboratories he masters product development and management.

Finding the right fit between the needs of the practitioners and the product marketed is the ultimate goal that Gaëtan is looking to achieve as a product manager at NeuroClues.

Frédérique Boël

Head of QARA

Linkedin

Frédérique is a civil engineer from UCL and has 5 years of experience as R&D engineer in the medical device industry.  During that time, she built-up practical experience in addressing quality and regulatory constraints applicable to large-scale medical device development.

She completed her expertise through the CARAQA.be University Certificate at UCL.

Within her role as head of P3Lab QARA, Frédérique aims at being an enabler to the development of safe and effective medical equipment, so as to ultimately make life easier for patients and practitioners.

Jean-Baptiste de Harenne

Chief Market Officer

Linkedin

Jean-Baptiste is mechanical engineer by training (with a minor in biomedical engineering) and holds an MBA from IESE. He has 10 years of experience in the operations in impact investing and in strategy consulting.

In his role, he connects with future users of the NeuroClues environment to ensure we map and answer the practicioners’ existing needs.

Jean-Baptiste is passionate about empowering the practicioners in performing their clinical exam and keen to ensure they can enjoy the best possible user experience 

Philippe Domineaux

Head of IT

Linkedin

Philippe is passionate about new technologies and wishes to use his knowledge for causes he considers useful.

He has over 15 years of experience in the hospital sector. He has held several positions in IT services dedicated to hospitals. In his previous position, he worked as a scientific IT manager and technical architect. A position he held for almost 11 years. He was in charge of developing and providing tools to researchers.

For P3Lab, as Head of IT, Philippe is in charge of the implementation and management of the IT infrastructure.

Bart Stulens

Chief Commercial Officer

Linkedin

With over 25 years of commercial and general management experience in the healthcare industry, including 16 years of senior leadership roles at Medtronic, Bart brings unparalleled expertise in implementing successful product launches and driving market expansion across multiple regions.

His addition to the team underscores neuroClues commitment to enhancing its commercial capabilities and accelerating its growth trajectory.

Audrey Bonnan

Head of Clinical

Linkedin

Strong of her experiences in clinical trial management et in Neuroscience research, Audrey joined NeuroClues as Head of Clinical to develop and oversee NeuroClues clinical program.

Audrey holds a PhD in Neuroscience from the University of Bordeaux and did her postdoctoral studies at the Max Planck Florida Institute for Neuroscience where she used oculomotor behaviors as a readout of cerebellar neuronal activity.

Audrey’s goal is to gather clinical evidence to demonstrate the potential of NeuroClues in measuring biomarkers of neurologic diseases.

Pierre Pouget

Scientific Advisor

Linkedin

Pierre Pouget is a recognized CNRS researcher working with key opinion leaders in neuroscience and a luminary scientist committed to increase awareness around mental health disabilities and diseases.

In La Pitié-Salpétrière, he is studying the wirings of the brain on primates, focusing on eye movements, and looking at specific brain structures (the frontal eye field, the supplementary eye field and the anterior cingulate regions of the brain). He is hoping that rules, laws and principles that govern the relations between structure and function within these specific areas of the brain can be generalized across, structures, functions and species so we can understand how our brain works.

Pierre is a co-founder of P³Lab, bringing over 20 years of experience in eye movement models of behavior.

Tymothée Poitou

Clinical Advisor

Tymothée has just finished his internship in physical medicine and rehabilitation and will continue his activity as assistant head of clinic in neurological rehabilitation. He is also a technology enthusiast driven by improving patient care through intersectoral fertilization. He develops applications as a hobby. He met Pierre Pouget, Pierre Daye and Bertrand Gaymard at the ICM (Brain and Spinal Cord Institute, Paris) during a Master 2 internship in Neurosciences.

Tymothée combines his clinical expertise and his tech savviness to advise us in developing a product that meets the practical concerns of its users.

Bao Nguyen

Marketing Advisor

Experienced Global Marketing Manager with an engineering background and an executive MBA degree, Bao has developed skills in research and development, product positioning, and strategic and operational Marketing, through his 10+ years of experience in the space industry and in radiation oncology with IBA.

Passionate about the mystery of the human body, he took up a new challenge and started medical school. In addition, he joined NeuroClues as a Clinical Marketing Advisor.

Marie Vidailhet

Director

Marie Vidailhet is Professor of Neurology at the Pitié-Salpêtrière Hospital, Sorbonne University, head of the “Abnormal movements and Parkinson’s” group and co-leader of the “Mov’It: Movement, Investigations, Therapeutics” research team at IC, whose thematic are the physiopathology of movement diseases and the research of biomarkers of these diseases. and in the scientific committee (board) of the European Academy of Neurology). She is a regular guest speaker at international congresses. and is strongly involved in the mentorship and training of young European neurologists. She participates in research consortia such as Dystonia Coalition (USA), Eurodyscover (Europe). She is or has been on the editorial board of international journals such as Mov Disord, J Neurology and Rev Neurol.

On the board of directors, she pursues scientific collaboration and ensures that developments correspond to the needs of neurological practice.

Olivier Legrain

President of the Board of Directors

Olivier Legrain is CEO of the Ion Beam Applications group since 2012. He has been instrumental in refocusing the business and maintaining the Company’s world leading position in proton therapy.

He graduated from from the Free University of Brussels (ULB) in 1992. After four years as auditor, he joined IBA SA in 1996 as Controller, was closely involved with the Company’s IPO in 1998 and since then, filled various Finance and Strategy positions inside the group. As a CEO, he not only grew IBA to a multinational company with a €1bn+ order book, but also achieved its B-Corp certification in 2021, proving its commitment to a sustainable business model including all stakeholders.

As chairman of the Board, Olivier challenges the management of P3Lab based on his strong business acumen and human approach.

Diane Lejeune

Board Member

Linkedin

Uniquely combining science and business, Diane has developed an end-to-end expertise in the development and commercialization of new medicines, vaccines, medical devices, diagnostics & digital health solutions, both in large companies and startups.

With experience in Venture Capital and in the board of director of companies, Diane is passionate about healthcare innovation, and her strengths reside in defining long-term strategy and translating it into what needs to be done to achieve success.

Today, she builds on these accumulated skills and knowledge to help startups and scale-ups in medical devices & digital health make a successful product our to their innovative idea.

Bertrand Gaymard

Bertrand Gaymard

Neurologist

Neurologist in the clinical neurophysiology department of Pitié-Salpêtrière, Paris, Bertrand Gaymard, MD, PhD, integrates the study of eye movements into functional neurological exploration. He is the co-author of numerous publications on the link between eye movements and neurological diseases. His clinical and experimental research activities focused on the physiology of ocular motor skills.

He brings to P3Lab his very rich experience in the study of eye movements in diagnostic aid, in particular of parkinsonian syndromes.

Aasef Shaikh

Aasef Shaikh

Neurologist

Aasef Shaikh, MD, PhD,  is Penni and Stephen Weinberg Chair in Brain Health, Vice Chair for Research, and Associate Professor of Neurology at Case Western Reserve University in Cleveland, Ohio, USA. He holds a scientific doctorate in neurophysiology.

Dr. Shaikh leads a multidisciplinary research team researching on neurodegenerative disorders, focused on the effects of neurologic interactions on eye movements and balance in function and modification by deep brain stimulation. He uses the eye movements as one of the biomarkers to assess the disease progression and the impact of the stimulation.

Dr. Shaikh brings to our project his tremendous knowledge about the latest research insights on neurodegenerative disease.

Like all our scientific advisors, Dr Shaikh is not being remunerated for his contribution.

Marie Laure Laborie

Marie-Laure Laborie

Orthoptist

President of the SFERO (Francophone Society for Studies and Research in Orthoptics), Marie-Laure Laborie is based in Montauban.

Unconditional advocate of the use of eye tracking to objectify the work of orthoptists, Marie-Laure enriches the development of the product through her experience and her perspectives on the needs of the profession of orthoptists.

Alessandra Rufa

Alessandra Rufa

Neurologist – ophtalmologist

Alessandra Rufa is MD, PhD, and Assistant Professor in Neurology, at the University of Siena (Italy). Her main interests are Clinical Neuro Ophthalmology, Neurodegenerative Diseases and Eye Movements research Dr. Rufa is the Director of the Neurosense research Lab, and head of EVALab clinical and research lab.  Dr Rufa and her multidisciplinary team, provide a comprehensive eye tracking competence including diagnosis of neurological diseases & cognitive neurosciences.

Dr. Rufa adds to our project the latest research insights on eye movements and her strong belief that their study can bring tremendous value in the daily life of clinician neurologists & ophtalmologists.

Eve Kannengieser

Orthoptist

Eve Kannengieser is president of the CNPO (National Professional Council of Orthoptists), administrator of the SFERO (Francophone Society of Study and Research in Orthoptics) and referent of its rehabilitation commission. She is based in Colmar, France.

Eve brings to the project her knowledge of the diagnosis and treatment of orthoptic disorders, as well as her passion to transmit science to help improve patients’ orthoptic care projects.

Thérèse Collins

Professor of cognitive science

Thérèse Collins is full professor in cognitive science at the University of Paris (previously known as Paris Descartes Univ). She is President of the Psychology and Ergonomics section of the Conseil National des Universités & co-director of the University’s  Cogmaster program and its cognitive psychology section

Thérèse brings to the project a wealth of knowledge and the latest research insights on eye movements in cognitive sciences

Book a virtual demo

Book a custom virtual walk-through of NeuroClues with one of our experts and see how our innovative eye-tracking technology could impact your clinical practice.

Go back to website